Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment.

To evaluate glucose metabolism in patients with tumors involving the liver, 35 patients with liver lesions had PET using 18F-2-fluoro-2-deoxy-D-glucose (FDG). FDG (148 MBq) was injected and radioactivity of the tumor was scanned dynamically by PET. The rate constants (k1, k2, k3, k4) of FDG in a metabolic model were calculated. The results were compared to hexokinase activity in the excised tumor specimens. k3 was found to reflect tumor hexokinase activity. When k3 was used as an index (cut-off value: 0.025), it was possible to distinguish benign and malignant tumors. k4 was significantly higher in hepatocellular carcinoma. By using k3 and k4 as indices, one could assess the degree of differentiation of hepatocellular carcinoma. After treatment, k3 decreased according to the effectiveness of therapy and thus may be a useful index for quantitatively assessing tumor viability.

[1]  C. Breedis,et al.  The blood supply of neoplasms in the liver. , 1954, The American journal of pathology.

[2]  H. Morris,et al.  Comparative biochemistry of hepatomas. II. Isotope studies of carbohydrate metabolism in Morris hepatoma 5123. , 1961, Cancer research.

[3]  H. Morris,et al.  COMPARATIVE BIOCHEMISTRY HEPATOMAS. IV. ISOTOPE STUDIES OF GLUCOSE AND FRUCTOSE METABOLISM IN LIVER TUMORS OF DIFFERENT GROWTH RATES. , 1963, Cancer research.

[4]  S. Weinhouse,et al.  GLUCOSE-ATP PHOSPHOTRANSFERASES DURING HEPATOCARCINOGENESIS. , 1965, Cancer research.

[5]  D. Burk,et al.  On the significance of glucolysis for cancer growth, with special reference to Morris rat hepatomas. , 1967, Journal of the National Cancer Institute.

[6]  A. Wolf,et al.  Metabolic trapping as a principle of oradiopharmaceutical design: some factors resposible for the biodistribution of [18F] 2-deoxy-2-fluoro-D-glucose. , 1978, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  N. K. Monakhov,et al.  Physicochemical properties and isoenzyme composition of hexokinase from normal and malignant human tissues. , 1978, Journal of the National Cancer Institute.

[8]  E. Hoffman,et al.  TOMOGRAPHIC MEASUREMENT OF LOCAL CEREBRAL GLUCOSE METABOLIC RATE IN HUMANS WITH (F‐18)2‐FLUORO-2‐DEOXY-D‐GLUCOSE: VALIDATION OF METHOD , 1980, Annals of neurology.

[9]  E. Takeda,et al.  Enzymology of human colon tumors. , 1980, Life sciences.

[10]  J. Hatazawa,et al.  Experimental study for cancer diagnosis with positron-labeled fluorinated glucose analogs: [18F]-2-fluoro-2-deoxy-D-mannose: A new tracer for cancer detection , 1982, European Journal of Nuclear Medicine.

[11]  C S Patlak,et al.  Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[12]  G. Chiro.  Positron emission tomography using [18F] fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool. , 1987 .

[13]  K. Herholz,et al.  Uncoupling of hexose transport and phosphorylation in human gliomas demonstrated by PET. , 1988, European journal of cancer & clinical oncology.